Evidence map›Paper›PMID 34071329›Full record

ArticleInternational journal of molecular sciences2021

Accelerated and Improved Vascular Maturity after Transplantation of Testicular Tissue in Hydrogels Supplemented with VEGF- and PDGF-Loaded Nanoparticles.

Federico Del Vento, Jonathan Poels, Maxime Vermeulen, Bernard Ucakar, Maria Grazia Giudice, Marc Kanbar, Anne des Rieux, Christine Wyns

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Hydrogels in Regenerative Medicine and Other Biomedical Applications.International journal of molecular sciences · 2022
    Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Federico Del VentoGynecology-Andrology Unit, Institute of Experimental and Clinical Research, Medical School, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.
Jonathan PoelsGynecology-Andrology Unit, Institute of Experimental and Clinical Research, Medical School, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.
Maxime VermeulenGynecology-Andrology Unit, Institute of Experimental and Clinical Research, Medical School, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0003-4021-4225
Bernard UcakarAdvanced Drug Delivery and Biomaterials Unit, Louvain Drug Research Institute, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.
Maria Grazia GiudiceGynecology-Andrology Unit, Institute of Experimental and Clinical Research, Medical School, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.
Marc KanbarGynecology-Andrology Unit, Institute of Experimental and Clinical Research, Medical School, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.
Anne des RieuxAdvanced Drug Delivery and Biomaterials Unit, Louvain Drug Research Institute, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0001-9953-3816
Christine WynsGynecology-Andrology Unit, Institute of Experimental and Clinical Research, Medical School, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0002-6581-5003
UCLouvain · BECliniques Universitaires Saint-Luc · BE

Funding

Fondation contre le Cancer 2016-141 FAF-C/2016/745
6 · The paper itself

Abstract

Avascular transplantation of frozen-thawed testicular tissue fragments represents a potential future technique for fertility restoration in boys with cancer. A significant loss of spermatogonia was observed in xeno-transplants of human tissue most likely due to the hypoxic period before revascularization. To reduce the effect of hypoxia-reoxygenation injuries, several options have already been explored, like encapsulation in alginate hydrogel and supplementation with nanoparticles delivering a necrosis inhibitor (NECINH) or VEGF. While these approaches improved short-term (5 days) vascular surfaces in grafts, neovessels were not maintained up to 21 days; i.e., the time needed for achieving vessel stabilization. To better support tissue grafts, nanoparticles loaded with VEGF, PDGF and NECINH were developed. Testicular tissue fragments from 4-5-week-old mice were encapsulated in calcium-alginate hydrogels, either non-supplemented (control) or supplemented with drug-loaded nanoparticles (VEGF-nanoparticles; VEGF-nanoparticles + PDGF-nanoparticles; NECINH-nanoparticles; VEGF-nanoparticles + NECINH-nanoparticles; and VEGF-nanoparticles + PDGF-nanoparticles + NECINH-nanoparticles) before auto-transplantation. Grafts were recovered after 5 or 21 days for analyses of tissue integrity (hematoxylin-eosin staining), spermatogonial survival (immuno-histo-chemistry for promyelocytic leukemia zinc finger) and vascularization (immuno-histo-chemistry for α-smooth muscle actin and CD-31). Our results showed that a combination of VEGF and PDGF nanoparticles increased vascular maturity and induced a faster maturation of vascular structures in grafts.

Indexed as

AlginatesAnimalsDrug LiberationFertility PreservationHumansHydrogelsMaleMiceMice, Inbred StrainsNanoparticlesNeovascularization, PhysiologicPlatelet-Derived Growth FactorSpermatogoniaTestisVascular Endothelial Growth Factor AAlginatesHydrogelsPlatelet-Derived Growth FactorVascular Endothelial Growth Factor Afertility preservationnanoparticlesnecrosis inhibitorPDGFspermatogonia stem cellstesticular tissue transplantationtissue engineeringvascular maturityVEGF

Identifiers

PMID34071329
PMCPMC8198558
OpenAlexW3164588290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.